Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Current Medical Research and Opinion
|
December 21, 2011
Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator
Jürgen Stein, Axel Dignass, Kai Uwe Chow
Radiology
|
October 29, 2015
Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals
Kai Uwe Chow, Beate Luxembourg, Erhard Seifried, et al.
Anti-Cancer Drugs
|
June 4, 2011
Cytotoxic effects of the trifunctional bispecific antibody FBTA05 in ex-vivo cells of chronic lymphocytic leukaemia depend on immune-mediated mechanism
Simone Boehrer, Petra Schroeder, Tina Mueller, et al.
Current Pharmaceutical Design
|
February 4, 2006
Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies
Simone Boehrer, Daniel Nowak, Dieter Hoelzer, et al.
Current Medicinal Chemistry
|
August 22, 2006
The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies
Simone Boehrer, Daniel Nowak, Dieter Hoelzer, et al.
Biochemical Pharmacology
|
September 2, 2003
Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation
Kai Uwe Chow, Daniel Nowak, Simone Boehrer, et al.
Cancer Immunology, Immunotherapy : CII
|
August 25, 2007
Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells
Tina Müller, Christoph Uherek, Guitta Maki, et al.
European Journal of Haematology
|
July 14, 2011
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia
Kai Uwe Chow, Soo-Zin Kim, Nils von Neuhoff, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
December 1, 2004
In malignant myeloid cells expression of Daxx downregulates expression of p53 and of the inhibitors of apoptosis proteins
Simone Boehrer, Daniel Nowak, Simone Schaaf, et al.
Leukemia & Lymphoma
|
December 29, 2004
Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)
Timo Wolf, Hans-Reinhard Brodt, Stephan Fichtlscherer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Current Medical Research and Opinion
|
December 21, 2011
Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator
Jürgen Stein, Axel Dignass, Kai Uwe Chow
Radiology
|
October 29, 2015
Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals
Kai Uwe Chow, Beate Luxembourg, Erhard Seifried, et al.
Anti-Cancer Drugs
|
June 4, 2011
Cytotoxic effects of the trifunctional bispecific antibody FBTA05 in ex-vivo cells of chronic lymphocytic leukaemia depend on immune-mediated mechanism
Simone Boehrer, Petra Schroeder, Tina Mueller, et al.
Current Pharmaceutical Design
|
February 4, 2006
Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies
Simone Boehrer, Daniel Nowak, Dieter Hoelzer, et al.
Current Medicinal Chemistry
|
August 22, 2006
The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies
Simone Boehrer, Daniel Nowak, Dieter Hoelzer, et al.
Biochemical Pharmacology
|
September 2, 2003
Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation
Kai Uwe Chow, Daniel Nowak, Simone Boehrer, et al.
Cancer Immunology, Immunotherapy : CII
|
August 25, 2007
Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells
Tina Müller, Christoph Uherek, Guitta Maki, et al.
European Journal of Haematology
|
July 14, 2011
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia
Kai Uwe Chow, Soo-Zin Kim, Nils von Neuhoff, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
December 1, 2004
In malignant myeloid cells expression of Daxx downregulates expression of p53 and of the inhibitors of apoptosis proteins
Simone Boehrer, Daniel Nowak, Simone Schaaf, et al.
Leukemia & Lymphoma
|
December 29, 2004
Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)
Timo Wolf, Hans-Reinhard Brodt, Stephan Fichtlscherer, et al.
Page
of 3